Furthermore, it has been shown that the Fas-FasR pathway is inhibited at the level of caspase-8 activation in glioblastoma patients, and that a lower caspase-8 expression is correlated with a poorer prognosis. The gene discussed is CASP8; the disease is glioblastoma.